Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Brent Ryan

Departmental Research Lecturer

I joined the University of Oxford in 2010 investigating animal and iPSC models of Parkinson's. Since becoming a Departmental Lecturer in 2021, my work has focused on combining new approaches such as post-translational proteomics, Crispr and high-throughput biology to identify new drugs and drug targets for Parkinson’s disease, with a focus on mitochondrial biology and quality control. My team has successfully identified novel targets for Parkinson’s using engineered and patient-derived iPSCs differentiated into dopaminergic neurons using novel post-translational and standard proteomics platforms. My team has also established phenotypic screening platforms in mature patient iPSC-derived neurons, primary rodent neurons and neuroblastoma to exploit proteomics targets and identify novel targets and chemical series’, some of which are being progressed into animal models.

Recent publications